|
1
|
Evaluation of an ultrasound-guided technique for central venous access via the internal jugular vein in 493 patients.
|
Support Care Cancer
|
2002
|
1.95
|
|
2
|
Clinical trials on CIK cells: first report of the international registry on CIK cells (IRCC).
|
J Cancer Res Clin Oncol
|
2010
|
1.67
|
|
3
|
Prognostic value of CA 19-9 levels in patients with inoperable adenocarcinoma of the pancreas treated with gemcitabine.
|
Br J Cancer
|
2003
|
1.57
|
|
4
|
Thalidomide in newly diagnosed multiple myeloma: influence of thalidomide treatment on peripheral blood stem cell collection yield.
|
Leukemia
|
2007
|
1.28
|
|
5
|
FDG-PET in immunocompetent patients with primary central nervous system lymphoma: correlation with MRI and clinical follow-up.
|
Eur J Nucl Med Mol Imaging
|
2005
|
1.21
|
|
6
|
Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C-reactive protein.
|
Eur J Clin Microbiol Infect Dis
|
2004
|
1.18
|
|
7
|
Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo.
|
Int Immunol
|
2006
|
0.99
|
|
8
|
Frequency of hereditary non-polyposis colorectal cancer among unselected patients with colorectal cancer in Germany.
|
Digestion
|
2006
|
0.99
|
|
9
|
Generation of dendritic cell-based vaccines for cancer therapy.
|
Br J Cancer
|
2002
|
0.94
|
|
10
|
An evidence-based evaluation of important aspects of empirical antibiotic therapy in febrile neutropenic patients.
|
Clin Microbiol Infect
|
2005
|
0.93
|
|
11
|
Acute transient encephalopathy after paclitaxel infusion: report of three cases.
|
Ann Oncol
|
2002
|
0.91
|
|
12
|
Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse model.
|
Gut
|
2004
|
0.90
|
|
13
|
Activated gammadelta T cells express the natural cytotoxicity receptor natural killer p 44 and show cytotoxic activity against myeloma cells.
|
Clin Exp Immunol
|
2006
|
0.89
|
|
14
|
The methionine synthase polymorphism D919G alters susceptibility to primary central nervous system lymphoma.
|
Br J Cancer
|
2004
|
0.88
|
|
15
|
MTX-induced white matter changes are associated with polymorphisms of methionine metabolism.
|
Neurology
|
2005
|
0.87
|
|
16
|
A recombinant anti-carcinoembryonic antigen immunoreceptor with combined CD3zeta-CD28 signalling targets T cells from colorectal cancer patients against their tumour cells.
|
Gut
|
2005
|
0.83
|
|
17
|
Low frequency of enteric infections by Salmonella, Shigella, Yersinia and Campylobacter in patients with acute leukemia.
|
Infection
|
2002
|
0.81
|
|
18
|
Coculture with dendritic cells promotes proliferation but not cytotoxic activity of gamma/delta T cells.
|
Immunol Lett
|
2005
|
0.80
|
|
19
|
Understanding and Targeting the Wnt/β-Catenin Signaling Pathway in Chronic Leukemia.
|
Leuk Res Treatment
|
2011
|
0.80
|
|
20
|
Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison.
|
Support Care Cancer
|
2003
|
0.78
|
|
21
|
Immunomodulatory gene therapy for haematological malignancies.
|
Br J Haematol
|
2002
|
0.77
|
|
22
|
Dendritic cell, the immunotherapeutic cell for cancer.
|
Indian J Med Res
|
2004
|
0.77
|
|
23
|
Weekly docetaxel in patients with pretreated metastatic breast cancer: a phase II trial.
|
Anticancer Drugs
|
2003
|
0.76
|
|
24
|
Wnt/ß-catenin: a new therapeutic approach to acute myeloid leukemia.
|
Leuk Res Treatment
|
2011
|
0.76
|
|
25
|
Impact of portable air filtration units on exposure of haematology-oncology patients to airborne Aspergillus fumigatus spores under field conditions.
|
J Hosp Infect
|
2003
|
0.75
|
|
26
|
Association of transcobalamin c. 776C>G with overall survival in patients with primary central nervous system lymphoma.
|
Br J Cancer
|
2012
|
0.75
|
|
27
|
Gene therapy for hematological malignancies.
|
Clin Exp Med
|
2003
|
0.75
|
|
28
|
Acute myeloid leukemia with near-triploid karyotype and extramedullary involvement of mediastinum.
|
Bone Marrow Transplant
|
2005
|
0.75
|
|
29
|
Sequential Hodgkin's and non-Hodgkin's lymphoma in non-immunocompromised patients.
|
Ann Hematol
|
2013
|
0.75
|
|
30
|
[Acute central nervous symptoms in oncologic patients].
|
Internist (Berl)
|
2005
|
0.75
|